Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …

In a prospective infant cohort, 21 infants developed Plasmodium vivax malaria during their
first year. Twelve of their mothers also had vivax malaria in the corresponding pregnancies or …

Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …

Background Effective antiviral drugs prevent hospitalisation and death from COVID-19.
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …

X-linked glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human
enzymopathy. The severe Mediterranean variant (G6PD Med) found across Europe and …

Background There are no pharmacokinetic data of single low dose primaquine (SLDPQ) as
transmission blocking in African children with acute Plasmodium falciparum and glucose-6-…

This study was performed to evaluate the incidence of and risk factors for Enterocytozoon
bieneusi carriage in an orphanage in Bangkok, Thailand. E. bieneusi has been identified by …

Background Uncertainty over the therapeutic benefit provided by parenteral remdesivir in
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …

Background Thailand is committed to eliminating malaria by 2024. From 2013 to 2020, the
total number of malaria cases have decreased, from 37,741 to 4474 (an 88.1% reduction). …

Background Molecular genotyping in Plasmodium serves many aims including providing
tools for studying parasite population genetics and distinguishing recrudescence from …